AAAAAA
Results: 1-25/77
Authors:
MYERS CE
Citation: Ce. Myers, CELEBRATING ASHPS GOLDEN ANNIVERSARY IN BEST PRACTICES, American journal of health-system pharmacy, 55(18), 1998, pp. 1879-1879
Authors:
GHOSH J
MYERS CE
Citation: J. Ghosh et Ce. Myers, ARACHIDONIC-ACID METABOLISM AND CANCER OF THE PROSTATE, Nutrition, 14(1), 1998, pp. 48-49
Authors:
MYERS CE
ERMITA BR
HASSELMO M
GLUCK MA
Citation: Ce. Myers et al., FURTHER IMPLICATIONS OF A COMPUTATIONAL MODEL OF SEPTOHIPPOCAMPAL CHOLINERGIC MODULATION IN EYEBLINK CONDITIONING, Psychobiology, 26(1), 1998, pp. 1-20
Authors:
THIBAULT A
FIGG WD
BERGAN RC
LUSH RM
MYERS CE
TOMPKINS A
REED E
SAMID D
Citation: A. Thibault et al., A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER, Tumori, 84(1), 1998, pp. 87-89
Authors:
GHOSH J
MYERS CE
Citation: J. Ghosh et Ce. Myers, INHIBITION OF ARACHIDONATE 5-LIPOXYGENASE TRIGGERS MASSIVE APOPTOSIS IN HUMAN PROSTATE-CANCER CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(22), 1998, pp. 13182-13187
Authors:
MYERS CE
Citation: Ce. Myers, CHASING THE CURVE OF INNOVATION - TRENDS FROM THE 1996 SURVEY, American journal of health-system pharmacy, 54(6), 1997, pp. 639-639
Authors:
MYERS CE
Citation: Ce. Myers, PROCEDURES FOR PREPARING INJECTABLE MEDICATIONS FOR LATEX-SENSITIVE PATIENTS, American journal of health-system pharmacy, 54(21), 1997, pp. 2517-2517
Authors:
MYERS CE
Citation: Ce. Myers, OVEREMPHASIS ON CREDENTIALS IN PERSONNEL ADS, American journal of health-system pharmacy, 54(11), 1997, pp. 1260-1260
Authors:
DESOUZA PL
COOPER MR
IMONDI AR
MYERS CE
Citation: Pl. Desouza et al., 9-AMINOCAMPTOTHECIN - A TOPOISOMERASE-I INHIBITOR WITH PRECLINICAL ACTIVITY IN PROSTATE-CANCER, Clinical cancer research, 3(2), 1997, pp. 287-294
Authors:
LEXA D
KEMATICK RJ
MYERS CE
Citation: D. Lexa et al., THE ACTIVITY OF COBALT AND SILICON IN THE CO-SI SYSTEM WITH SPECIAL FOCUS ON THE ALPHA-CO SOLID-SOLUTION, Metallurgical and materials transactions. A, Physical metallurgy andmaterials science, 28(4), 1997, pp. 909-915
Authors:
GLUCK MA
ERMITA BR
OLIVER LM
MYERS CE
Citation: Ma. Gluck et al., EXTENDING MODELS OF HIPPOCAMPAL FUNCTION IN ANIMAL CONDITIONING TO HUMAN AMNESIA, Memory, 5(1-2), 1997, pp. 179-212
Authors:
DAWSON NA
FIGG WD
COOPER MR
SARTOR O
BERGAN RC
SENDEROWICZ AM
STEINBERG SM
TOMPKINS A
WEINBERGER B
SAUSVILLE EA
REED E
MYERS CE
Citation: Na. Dawson et al., PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1470-1477
Authors:
GLUCK MA
MYERS CE
Citation: Ma. Gluck et Ce. Myers, PSYCHOBIOLOGICAL MODELS OF HIPPOCAMPAL FUNCTION IN LEARNING AND MEMORY, Annual review of psychology, 48, 1997, pp. 481-514
Authors:
DESOUZA PL
CASTILLO M
MYERS CE
Citation: Pl. Desouza et al., ENHANCEMENT OF PACLITAXEL ACTIVITY AGAINST HORMONE-REFRACTORY PROSTATE-CANCER CELLS IN-VITRO AND IN-VIVO BY QUINACRINE, British Journal of Cancer, 75(11), 1997, pp. 1593-1600
Authors:
GHOSH J
MYERS CE
Citation: J. Ghosh et Ce. Myers, ARACHIDONIC-ACID STIMULATES PROSTATE-CANCER CELL-GROWTH - CRITICAL ROLE OF 5-LIPOXYGENASE, Biochemical and biophysical research communications, 235(2), 1997, pp. 418-423
Authors:
BATES DW
BURROWS AM
GROSSMAN DGS
SCHNEIDER PJ
STROM BL
MYERS CE
CRANSTON JW
ONEAL DJ
COHEN SS
COUSINS DD
FINK L
MUNDT RL
NADZAM D
KING CM
SANTELL JP
WILFINGER RG
ZELLMER WA
Citation: Dw. Bates et al., TOP-PRIORITY ACTIONS FOR PREVENTING ADVERSE DRUG EVENTS IN HOSPITALS - RECOMMENDATIONS OF AN EXPERT PANEL, American journal of health-system pharmacy, 53(7), 1996, pp. 747-751
Authors:
MYERS CE
Citation: Ce. Myers, CORRECTIONAL FACILITIES GUIDELINES, American journal of health-system pharmacy, 53(3), 1996, pp. 320
Authors:
MYERS CE
Citation: Ce. Myers, NEEDED - SERIOUS ATTENTION TO STERILE PRODUCTS, American journal of health-system pharmacy, 53(21), 1996, pp. 2582-2582
Authors:
MYERS CE
Citation: Ce. Myers, ERGONOMICS AND MEDICATION ERRORS, American journal of health-system pharmacy, 53(15), 1996, pp. 1784-1785
Authors:
STEIN GC
MYERS CE
Citation: Gc. Stein et Ce. Myers, LIMITATIONS OF THE NEW OSHA DOCUMENT ON CONTROLLING OCCUPATIONAL EXPOSURE TO HAZARDOUS DRUGS, American journal of health-system pharmacy, 53(14), 1996, pp. 1717-1719
Authors:
THIBAULT A
SAMID D
TOMPKINS AC
FIGG WD
COOPER MR
HOHL RJ
TREPEL J
LIANG B
PATRONAS N
VENZON DJ
REED E
MYERS CE
Citation: A. Thibault et al., PHASE-I STUDY OF LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY, IN PATIENTS WITH CANCER, Clinical cancer research, 2(3), 1996, pp. 483-491
Authors:
MYERS CE
ERMITA BR
HARRIS K
HASSELMO M
SOLOMON P
GLUCK MA
Citation: Ce. Myers et al., COMPUTATIONAL MODEL OF CHOLINERGIC DISRUPTION OF SEPTOHIPPOCAMPAL ACTIVITY IN CLASSICAL EYEBLINK CONDITIONING, Neurobiology of learning and memory, 66(1), 1996, pp. 51-66
Authors:
GLUCK MA
OLIVER LM
MYERS CE
Citation: Ma. Gluck et al., LATE-TRAINING AMNESIC DEFICITS IN PROBABILISTIC CATEGORY LEARNING - ANEUROCOMPUTATIONAL ANALYSIS, Learning & memory, 3(4), 1996, pp. 326-340
Authors:
GLUCK MA
MYERS CE
Citation: Ma. Gluck et Ce. Myers, INTEGRATING BEHAVIORAL AND PHYSIOLOGICAL MODELS OF HIPPOCAMPAL FUNCTION, Hippocampus, 6(6), 1996, pp. 643-653
Authors:
SCHLAIFER D
DUCHAYNE E
DEMUR C
ALVINERIE P
MULLER C
ATTAL M
COOPER MR
PAYEN C
MONSARRAT B
MYERS CE
PRIS J
LAURENT G
Citation: D. Schlaifer et al., VINCRISTINE DEGRADATION BY SERUM FROM LEUKEMIC PATIENTS - ROLE OF MYELOPEROXIDASE, Leukemia & lymphoma, 20(5-6), 1996, pp. 441-446